263 related articles for article (PubMed ID: 1338666)
1. [Morphological diagnosis and prognosis in early ductal breast cancer].
Frank GA; Volchenko NN
Vopr Onkol; 1992; 38(3):299-310. PubMed ID: 1338666
[TBL] [Abstract][Full Text] [Related]
2. [Pathology of premalignant and malignant diseases of the female breast].
Prechtel K
Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir; 1989; ():897-900. PubMed ID: 2577661
[TBL] [Abstract][Full Text] [Related]
3. [Morphology, topography and growth pattern of benign proliferative breast lesions and pre-invasive cancers].
Böcker W; Jarasch ED; Nagle EB; Höhne R
Verh Dtsch Ges Pathol; 1985; 69():96-107. PubMed ID: 3006396
[No Abstract] [Full Text] [Related]
4. [Pre-invasive tumors and precancerous conditions of the breast: pathologico-anatomic demarcation and clinical consequences].
Bässler R; Werner J
Chirurg; 1984 Mar; 55(3):133-41. PubMed ID: 6325099
[No Abstract] [Full Text] [Related]
5. Definition of precancerous and high-risk mammary lesions.
Bégin LR
Can J Surg; 1985 May; 28(3):248-51. PubMed ID: 2986807
[TBL] [Abstract][Full Text] [Related]
6. [Breast cancer].
Van Bogaert LJ
Rev Fr Gynecol Obstet; 1984 May; 79(5):361-98. PubMed ID: 6098952
[No Abstract] [Full Text] [Related]
7. [Diseases of the female breast: clinical pathology].
Torhorst J
Ther Umsch; 1993 May; 50(5):307-13. PubMed ID: 8397447
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of selected immunohistochemical parameters in patients with invasive breast carcinoma concomitant with ductal carcinoma in situ.
Patla A; Rudnicka-Sosin L; Pawlega J; Stachura J
Pol J Pathol; 2002; 53(1):25-7. PubMed ID: 12014222
[TBL] [Abstract][Full Text] [Related]
9. 17 beta-Hydroxysteroid dehydrogenase type 1 and type 2 in ductal carcinoma in situ and intraductal proliferative lesions of the human breast.
Ariga N; Moriya T; Suzuki T; Kimura M; Ohuchi N; Satomi S; Sasano H
Anticancer Res; 2000; 20(2B):1101-8. PubMed ID: 10810403
[TBL] [Abstract][Full Text] [Related]
10. Molecular evidence for progression of microglandular adenosis (MGA) to invasive carcinoma.
Shin SJ; Simpson PT; Da Silva L; Jayanthan J; Reid L; Lakhani SR; Rosen PP
Am J Surg Pathol; 2009 Apr; 33(4):496-504. PubMed ID: 19047897
[TBL] [Abstract][Full Text] [Related]
11. [Tubular carcinoma of the breast (clinico-morphological characteristics)].
Frank GA; Volchenko NN
Vopr Onkol; 1985; 31(5):15-21. PubMed ID: 2990106
[TBL] [Abstract][Full Text] [Related]
12. Predictors of residual invasive disease after core needle biopsy diagnosis of ductal carcinoma in situ.
Rutstein LA; Johnson RR; Poller WR; Dabbs D; Groblewski J; Rakitt T; Tsung A; Kirchner T; Sumkin J; Keenan D; Soran A; Ahrendt G; Falk JS
Breast J; 2007; 13(3):251-7. PubMed ID: 17461899
[TBL] [Abstract][Full Text] [Related]
13. Ductal carcinoma of the breast. An analysis of proportions of intraductal and invasive components.
Matsukuma A; Enjoji M; Toyoshima S
Pathol Res Pract; 1991 Jan; 187(1):62-7. PubMed ID: 1851298
[TBL] [Abstract][Full Text] [Related]
14. Mammographically detected, clinically occult ductal carcinoma in situ treated with breast-conserving surgery and definitive breast irradiation.
Solin LJ; McCormick B; Recht A; Haffty BG; Taylor ME; Kuske RR; Bornstein BA; McNeese M; Schultz DJ; Fowble BL; Barrett W; Yeh IT; Kurtz JM; Amalric R; Fourquet A
Cancer J Sci Am; 1996; 2(3):158-65. PubMed ID: 9166516
[TBL] [Abstract][Full Text] [Related]
15. [Automated microscopic image analysis and the prognosis of preneoplasms and carcinomas of the mammary gland].
Guski H; Hufnagl P; Freitag A; Winzer KJ
Gegenbaurs Morphol Jahrb; 1989; 135(1):39-53. PubMed ID: 2544475
[TBL] [Abstract][Full Text] [Related]
16. Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma.
Khalifeh IM; Albarracin C; Diaz LK; Symmans FW; Edgerton ME; Hwang RF; Sneige N
Am J Surg Pathol; 2008 Apr; 32(4):544-52. PubMed ID: 18300793
[TBL] [Abstract][Full Text] [Related]
17. Ductal carcinoma in situ in core biopsies containing invasive breast cancer: correlation with extensive intraductal component and lumpectomy margins.
Dzierzanowski M; Melville KA; Barnes PJ; MacIntosh RF; Caines JS; Porter GA
J Surg Oncol; 2005 May; 90(2):71-6. PubMed ID: 15844190
[TBL] [Abstract][Full Text] [Related]
18. Stereotaxic fine needle aspiration cytology of clinically occult malignant and premalignant breast lesions.
Bibbo M; Scheiber M; Cajulis R; Keebler CM; Wied GL; Dowlatshahi K
Acta Cytol; 1988; 32(2):193-201. PubMed ID: 2831687
[TBL] [Abstract][Full Text] [Related]
19. Is core needle biopsy superior to fine-needle aspiration biopsy in the diagnosis of papillary breast lesions?
Masood S; Loya A; Khalbuss W
Diagn Cytopathol; 2003 Jun; 28(6):329-34. PubMed ID: 12768640
[TBL] [Abstract][Full Text] [Related]
20. The role of CXCR4 receptor expression in breast cancer: a large tissue microarray study.
Salvucci O; Bouchard A; Baccarelli A; Deschênes J; Sauter G; Simon R; Bianchi R; Basik M
Breast Cancer Res Treat; 2006 Jun; 97(3):275-83. PubMed ID: 16344916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
